IGIC International General Insurance Holdings Ltd Ordinary Share Q4 2025 revenue rises 102 percent shares gain 181 percent despite slight EPS miss CNDT Conduent Incorporated posts wider Q4 2025 loss yet shares rise nearly three percent amid resilient investor sentiment The scenario planning at Santander CL BSAC Q4 2025 EPS Beats Forecasts OLOX Olenox Industries Inc shares climb 587 percent as narrower than expected Q3 2023 loss offsets steep annual revenue decline IQVIA Holdings Assessing Wall Street Analysts Outlook After Stock Lags SP 500 Geosphere Capitals Arvind Sanger Cautiously Optimistic on India Amid Global Liquidity Outlook Best CD Rates Reach 4 APY on May 27 2026 What Savers Need to Know Nifty 50s LongTerm Performance Sends Reassuring Signal to FPIs Amid Current Challenges Apex Service Sells Minority Stake to Apollo at 10 Billion Valuation Source Reports Wingstop Shares Slide 12 After Earnings Profit Misses Estimates AARD Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress Niagen Bioscience Inc NAGE Q1 2026 Earnings EPS Beats Estimates by 086 but Stock Declines 343 DINO Q1 2026 Earnings Massive EPS Beat Driven by Strong Refining Margins Washington Trust Bancorp Inc WASH Q1 2026 Earnings Earnings Miss Sends Mixed Signals as Shares Inch Higher Corpay Inc CPAY Q1 2026 Earnings EPS Surpasses Estimates Amid Steady Performance TNXP Q1 2026 Earnings WiderThanExpected Loss Amid Continued Pipeline Development CorMedix CRMD Rises 242 as Momentum Builds Toward Key Resistance Axalta Coating Systems AXTA Slips Slightly as Stock Navigates Between Key Support and Resistance Levels T Stamp Inc IDAI Gains 39 as Buyers Test Key Resistance at 252 Olaplex Holdings OLPX Holds Steady Near Support as Traders Eye Breakout Potential Central Puerto CEPU Springs Over 6 as Bullish Momentum Builds Should You Let a Prospective Employer Contact Your Current Boss Key Considerations for Job Seekers Carriage Services Inc CSV Q1 2026 Earnings Modest EPS Beat Amid Flat Revenue and Negative Stock Reaction NewAmsterdam Pharma NAMS Slightly Lower Amid Consolidation Near Key Support Levels